Title: Randomised controlled trial for emphysema with a selective agonist of the γ-type retinoic acid receptor.
Journal: The European respiratory journal 20120801
Title: The COPD Pipeline XIII.
Journal: COPD 20111201
Title: Potent inhibition of heterotopic ossification by nuclear retinoic acid receptor-γ agonists.
Journal: Nature medicine 20110401
Title: Retinoid treatment of Emphysema in Patients on the Alpha-1 International Registry. The REPAIR study: study design, methodology and quality control of study assessments.
Journal: Therapeutic advances in respiratory disease 20101201
Title: The COPD pipeline VII.
Journal: COPD 20101201
Title: Palovarotene, a novel retinoic acid receptor gamma agonist for the treatment of emphysema.
Journal: Current opinion in investigational drugs (London, England : 2000) 20091101
Title: Treatment of patients who have fibrodysplasia ossificans progressiva with isotretinoin.
Journal: Clinical orthopaedics and related research 19980101
Title: Pavey GJ, et al. Targeted stimulation of retinoic acid receptor-γ mitigates the formation of heterotopic ossification in an established blast-related traumatic injury model. Bone. 2016 Sep;90:159-67.
Title: Chakkalakal SA, et al. Palovarotene Inhibits Heterotopic Ossification and Maintains Limb Mobility and Growth in Mice With the Human ACVR1(R206H) Fibrodysplasia Ossificans Progressiva (FOP) Mutation. J Bone Miner Res. 2016 Sep;31(9):1666-75.
Title: Lees-Shepard JB, et al. Palovarotene reduces heterotopic ossification in juvenile FOP mice but exhibits pronounced skeletal toxicity. Elife. 2018 Sep 18;7. pii: e40814.
